Literature DB >> 7593127

Progress against cancer.

S Broder1, J E Karp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593127     DOI: 10.1007/BF01218521

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  127 in total

Review 1.  Hereditary prostate cancer: epidemiologic and clinical features.

Authors:  B S Carter; G S Bova; T H Beaty; G D Steinberg; B Childs; W B Isaacs; P C Walsh
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

2.  Susceptibility genes for breast cancer.

Authors:  B L Weber
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

3.  Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential.

Authors:  P Delli-Bovi; A M Curatola; K M Newman; Y Sato; D Moscatelli; R M Hewick; D B Rifkin; C Basilico
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

4.  Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.

Authors:  W H Lee; R A Morton; J I Epstein; J D Brooks; P A Campbell; G S Bova; W S Hsieh; W B Isaacs; W G Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

5.  Microsatellite alterations as clonal markers for the detection of human cancer.

Authors:  L Mao; D J Lee; M S Tockman; Y S Erozan; F Askin; D Sidransky
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

6.  The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer.

Authors:  P Watson; H F Vasen; J P Mecklin; H Järvinen; H T Lynch
Journal:  Am J Med       Date:  1994-06       Impact factor: 4.965

7.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.

Authors:  H Matsushime; M F Roussel; R A Ashmun; C J Sherr
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

8.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

9.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

10.  MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast.

Authors:  T A Prolla; Q Pang; E Alani; R D Kolodner; R M Liskay
Journal:  Science       Date:  1994-08-19       Impact factor: 47.728

View more
  5 in total

Review 1.  Spontaneous regression of pancreatic cancer: real or a misdiagnosis?

Authors:  Marta Herreros-Villanueva; Elizabeth Hijona; Angel Cosme; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

2.  Short-term spontaneous regression of myxofibrosarcoma in the scapular region.

Authors:  Akio Sakamoto; Eisuke Shiba; Masanori Hisaoka
Journal:  Skeletal Radiol       Date:  2014-06-10       Impact factor: 2.199

Review 3.  Spontaneous regression of colorectal cancer: a review of cases from 1900 to 2005.

Authors:  Ayman S Abdelrazeq
Journal:  Int J Colorectal Dis       Date:  2006-12-05       Impact factor: 2.796

4.  Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection.

Authors:  A Mutirangura; C Tanunyutthawongese; W Pornthanakasem; V Kerekhanjanarong; V Sriuranpong; S Yenrudi; P Supiyaphun; N Voravud
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Spontaneous Regression of a Carcinoid Tumor following Pregnancy.

Authors:  A Sewpaul; D Bargiela; A James; S J Johnson; J J French
Journal:  Case Rep Endocrinol       Date:  2014-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.